Immix Biopharma, Inc.
IMMX
Revenue
20.00M
▲20.00M∞%
-Assets
22.95M
▼-2.19M▼-8.73%
3 Months ChangeLiabilities
9.70M
▲2.11M▲27.74%
3 Months ChangeFree Cash Flow
-4.13M
▼-3.86M▼-1444.92%
36 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-08-12
Form 10-Q
ID: 0001493152-24-031358
2024-07-26
Form 8-K
ID: 0001493152-24-029174
2024-07-22
Form 8-K
ID: 0001493152-24-028595
2024-06-14
Form 8-K
ID: 0001493152-24-023947
2024-05-20
Form 8-K
ID: 0001493152-24-020785
2024-05-09
Form 10-Q
ID: 0001493152-24-018458
2024-02-06
Form 8-K
ID: 0001493152-24-005043
2024-02-05
Form 8-K
ID: 0001493152-24-004933
2023-11-13
Form 10-Q
ID: 0001493152-23-040182
2023-08-22
Form 8-K
ID: 0001493152-23-029822